Wells Fargo & Company »

Edgewise Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $373k 20k 18.24
2023-12-31 $144k 13k 10.94
2023-09-30 $61k 11k 5.73
2023-06-30 $126k 16k 7.75
2022-09-30 $1.0k 59 16.95
2022-06-30 $2.0k 256 7.81
2022-03-31 $38k 3.9k 9.66
2021-12-31 $273k 18k 15.29